Bricanyl (Terbutaline Sulfate Inhaler)

Bricanyl (Terbutaline Sulfate Inhaler) is filed as Short-Acting Beta Agonist. The sections below restate public label fields stored for this profile.

Class
Short-Acting Beta Agonist
Generic name
Terbutaline Sulfate Inhaler
Route
ORAL
Dosage forms
HOW SUPPLIED Terbutaline sulfate tablets, USP are packaged in bottles of 100 and 1000 tablets. Descriptions of the 2.5 and 5 mg tablets follow: Tablets 2.5 mg - White to off-white, oval tablets, scored on one side and engraved with “T132” on the other side Bottles of 30 NDC 71205-938-30 Bottles of 60 NDC 71205-938-60 Bottles of 90 NDC 71205-938-90 Bottles of 100 NDC 71205-938-00 Bottles of 500 NDC 71205-938-55 Tablets 5 mg - White to off-white, round, scored and engraved “T” above and “133” below the score on the scored side. Bottles of 30 NDC 71205-939-30 Bottles of 60 NDC 71205-939-60 Bottles of 90 NDC 71205-939-90 Bottles of 100 NDC 71205-939-00 Bottles of 500 NDC 71205-939-55 Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure Manufactured for: TWi Pharmaceuticals USA, Inc. Paramus, NJ 07652 Manufactured by: TWi Pharmaceuticals, Inc. Taoyuan City, 32063, Taiwan Rev. 07/19 Repackaged and Relabeled by: Proficient Rx LP Thousand Oaks, CA 91320 image description
Generic available
Yes
Manufacturer
Proficient Rx LP
Boxed warning
Yes

Approved uses

Prevention and treatment of bronchospasm in patients with reversible obstructive airway disease

How it works

Terbutaline is a short-acting beta-2 adrenergic agonist that relaxes bronchial smooth muscle by stimulating beta-2 receptors. It has a slightly longer duration of action than albuterol.

Boxed warning

WARNING: TOCOLYSIS Oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis. In particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting. Serious adverse reactions, including death, have been reported after administration of terbutaline sulfate to pregnant women. In the mother, these adverse reactions include increased heart rate, transient hyperglycemia, hypokalemia, cardiac arrhythmias, pulmonary edema and myocardial ischemia. Increased fetal heart rate and neonatal hypoglycemia may occur as a result of maternal administration. [see Contraindications, Tocolysis . ]

Warnings and precautions

May cause tremor, nervousness, tachycardia. Use with caution in cardiovascular disorders. Paradoxical bronchospasm possible.

Contraindications

1. Tocolysis Oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis [see Boxed Warning: Tocolysis ].

Adverse reactions

Adverse reactions observed with terbutaline sulfate are similar to those commonly seen with other sympathomimetic amines. All of these reactions are generally transient in nature and usually do not require treatment. The frequency of these side effects appears to diminish with continued therapy. The following table lists the adverse reactions seen in 199 patients treated with terbutaline sulfate tablets during six double-blind crossover studies and four double-blind parallel studies (short- and long-term) performed in the United States. Percent Incidence of Adverse Reactions (Total Daily Dosage Range 5 to 15 mg) Terbutaline N=199 Reaction % Nervous System Nervousness 35.0 Tremor 15.0 Somnolence 5.5 Dizziness 3.5 Anxiety 1.0 Insomnia 1.5 Cardiovascular Palpitations 5.0 Tachycardia 3.5 Extrasystoles ventricular 1.5 Vasodilations 1.0 Digestive Nausea 3.0 Dry mouth 1.5 Body as a Whole Headache 7.5 Asthenia 2.0 Skin and Appendages Sweating 1.0 The following adverse effects each occurred in fewer than 1% of patients: hallucinations, rash, paresthesia, hypertonia, (muscle cramps), vomiting. There have been rare reports of elevations in liver enzymes and of hypersensitivity vasculitis.

Dosage and administration

Adults The usual oral dose of terbutaline sulfate for adults is 5 mg administered at approximately six-hour intervals, three times daily, during the hours the patient is usually awake. If side effects are particularly disturbing, the dose may be reduced to 2.5 mg three times daily, and still provide a clinically significant improvement in pulmonary function. The total dose within 24 hours should not exceed 15 mg. Children Terbutaline sulfate is not recommended for use in children below the age of 12 years. A dosage of 2.5 mg three times daily is recommended for children 12 to 15 years of age. The total dose within 24 hours should not exceed 7.5 mg. If a previously effective dosage regimen fails to provide the usual relief, medical advice should be sought immediately as this is often a sign of seriously worsening asthma that would require reassessment of therapy.

Drug interactions

Drug Interactions The concomitant use of terbutaline sulfate with other sympathomimetic agents is not recommended, since the combined effect on the cardiovascular system may be deleterious to the patient. However, this does not preclude the use of an aerosol bronchodilator of the adrenergic-stimulant type for the relief of an acute bronchospasm in patients receiving chronic oral therapy with terbutaline sulfate.

Common questions

What is Bricanyl approved to treat?

According to its FDA label, Bricanyl (Terbutaline Sulfate Inhaler) is approved for: Prevention and treatment of bronchospasm in patients with reversible obstructive airway disease For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Bricanyl?

Bricanyl (Terbutaline Sulfate Inhaler) belongs to the Short-Acting Beta Agonist class of medications.

What form does Bricanyl come in?

The FDA label lists Bricanyl (Terbutaline Sulfate Inhaler) as: HOW SUPPLIED Terbutaline sulfate tablets, USP are packaged in bottles of 100 and 1000 tablets. Descriptions of the 2.5 and 5 mg tablets follow: Tablets 2.5 mg - White to off-white, oval tablets, scored on one side and engraved with “T132” on the other side Bottles of 30 NDC 71205-938-30 Bottles of 60 NDC 71205-938-60 Bottles of 90 NDC 71205-938-90 Bottles of 100 NDC 71205-938-00 Bottles of 500 NDC 71205-938-55 Tablets 5 mg - White to off-white, round, scored and engraved “T” above and “133” below the score on the scored side. Bottles of 30 NDC 71205-939-30 Bottles of 60 NDC 71205-939-60 Bottles of 90 NDC 71205-939-90 Bottles of 100 NDC 71205-939-00 Bottles of 500 NDC 71205-939-55 Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure Manufactured for: TWi Pharmaceuticals USA, Inc. Paramus, NJ 07652 Manufactured by: TWi Pharmaceuticals, Inc. Taoyuan City, 32063, Taiwan Rev. 07/19 Repackaged and Relabeled by: Proficient Rx LP Thousand Oaks, CA 91320 image description; oral route. Available strengths and packaging vary by manufacturer.

Is there a generic version of Bricanyl?

Yes. A generic version of Bricanyl (Terbutaline Sulfate Inhaler) is available in the U.S. Ask your pharmacist about substitution.

Does Bricanyl have a Boxed Warning?

Yes. The FDA label for Bricanyl (Terbutaline Sulfate Inhaler) carries a Boxed Warning. Excerpt: "WARNING: TOCOLYSIS Oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis. In particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatie…" See the full FDA label for the complete warning. For medical advice, please talk to your prescriber or pharmacist.

How much does Bricanyl cost?

Public CMS NADAC pricing for Bricanyl (Terbutaline Sulfate Inhaler) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.

Is Bricanyl currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Bricanyl (Terbutaline Sulfate Inhaler) in our latest ingest. Recall data can change daily — verify at FDA.gov.

When was Bricanyl approved by the FDA?

The FDA record lists the approval date for Bricanyl (Terbutaline Sulfate Inhaler) as 2020-06-19.

Who makes Bricanyl?

The FDA label lists Proficient Rx LP as a labeler/manufacturer of Bricanyl (Terbutaline Sulfate Inhaler). Multiple firms may market generics of the same molecule.

How should Bricanyl be stored?

The FDA label states: "Terbutaline sulfate tablets, USP are packaged in bottles of 90 tablets. Descriptions of the 2.5 and 5 mg tablets follow: Tablets 2.5 mg—round, white, scored (imprinted LCI over 1318) Bottles of 90 NDC 62135-524-90 Tablet…" Follow the packaging insert for the authoritative guidance.

What is the pregnancy category for Bricanyl?

The FDA label lists a pregnancy category of C for Bricanyl (Terbutaline Sulfate Inhaler). Pregnancy and lactation decisions should be made with a clinician.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…